Clapham, Hannah E

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., et al. (2021) · Journal of Experimental Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 330

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., et al. (2021) · The Lancet

Vaccine Coverage and HesitancyImmune responses and vaccinations

Cited by 300

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world

Toor, J., Echeverria-Londono, S., Li, X., Abbas, K., Carter, E. D., Clapham, H. E., Clark, A., de Villiers, M. J., Eilertson, K., Ferrari, M., et al. (2021) · eLife

Vaccine Coverage and HesitancyImmune responses and vaccinations

Cited by 97